{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:04:16Z","timestamp":1785449056922,"version":"3.56.0"},"reference-count":21,"publisher":"Consilium Medicum","issue":"7","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>Aim. Testing of therapeutic drug monitoring in the treatment of drug-resistant tuberculosis.\r\nMaterials and methods. We conducted a pilot prospective study including 15 patients with drug-resistant tuberculosis. Serum concentrations of bedaquiline, linezolid, fluoroquinolone, cycloserine, delamanid (C2h) were determined by high-performance liquid chromatography and mass spectrometry. The influence of clinical and pharmacogenetic factors were evaluated.\r\nResults. In most patients, C2h of the drugs were subtherapeutic (57.1% for bedaquiline, 73.3% for linezolid). C2h of bedaquiline were higher in patients with homozygous rs776746 in the CYP3A5 gene (p=0.04), in case of simultaneous omeprazole (p=0.015), high drug load (p=0.005); linezolid \u2013 in patients with rs776746 in the CYP3A5 gene (p=0.038) and rs34351236 in the P-glycoprotein gene (p=0.014). The course of chemotherapy was effective in 14 of 15 patients. A factor for cavity closure was a C2h\/critical concentration ratio above 1.0 for fluoroquinolone (odds ratio 3.5, 95% confidence interval 1.08\u201311.24).\r\nConclusion. Therapeutic drug monitoring is a perspective tool for personalized approach to improve treatment outcomes in high-risk drug-resistant tuberculosis patients.<\/jats:p>","DOI":"10.26442\/00403660.2026.07.203678","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:55:47Z","timestamp":1785448547000},"page":"413-418","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic drug monitoring in the treatment of patients with drug-resistant tuberculosis"],"prefix":"10.26442","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5686-536X","authenticated-orcid":false,"given":"Diana A.","family":"Ivanova","sequence":"additional","affiliation":[{"name":"The Moscow Research and Clinical Center for Tuberculosis Control"},{"name":"Russian Medical Academy of Continuous Professional Education"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4681-550X","authenticated-orcid":false,"given":"Ekaterina I.","family":"Yurovskaya","sequence":"additional","affiliation":[{"name":"The Moscow Research and Clinical Center for Tuberculosis Control"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4037-9067","authenticated-orcid":false,"given":"Ksenia Yu.","family":"Galkina","sequence":"additional","affiliation":[{"name":"The Moscow Research and Clinical Center for Tuberculosis Control"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4418-4601","authenticated-orcid":false,"given":"Mikhail N.","family":"Reshetnikov","sequence":"additional","affiliation":[{"name":"The Moscow Research and Clinical Center for Tuberculosis Control"},{"name":"Russian Medical Academy of Continuous Professional Education"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6659-7888","authenticated-orcid":false,"given":"Dmitrii V.","family":"Plotkin","sequence":"additional","affiliation":[{"name":"The Moscow Research and Clinical Center for Tuberculosis Control"},{"name":"Pirogov Russian National Research Medical University (Pirogov University)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4803-9257","authenticated-orcid":false,"given":"Natalia V.","family":"Litvinova","sequence":"additional","affiliation":[{"name":"The Moscow Research and Clinical Center for Tuberculosis Control"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18344","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"ref1","unstructured":"Global tuberculosis report 2024. Geneva: World Health Organization, 2024. Available at: https:\/\/iris.who.int\/bitstream\/handle\/10665\/379339\/9789240101531-eng.pdf?sequence=1. Accessed: 13.05.2025."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.26442\/00403660.2020.08.000762"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.26442\/00403660.2024.08.202812"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12121394"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21292\/2075-1230-2020-98-1-5-15"},{"key":"ref6","unstructured":"\u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u0444\u0430\u0440\u043c\u0430\u043a\u043e\u043b\u043e\u0433\u0438\u044f: \u043d\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u043e\u0435 \u0440\u0443\u043a\u043e\u0432\u043e\u0434\u0441\u0442\u0432\u043e. \u041f\u043e\u0434 \u0440\u0435\u0434. \u0412.\u0418. \u041f\u0435\u0442\u0440\u043e\u0432\u0430, \u0414.\u0410. \u0421\u044b\u0447\u0435\u0432\u0430, \u0410.\u041b. \u0425\u043e\u0445\u043b\u043e\u0432\u0430. 2-\u0435 \u0438\u0437\u0434. \u041c.: \u0413\u042d\u041e\u0422\u0410\u0420-\u041c\u0435\u0434\u0438\u0430, 2024 [Klinicheskaia farmakologiia: natsionalnoe rukovodstvo. Pod red. VI Petrova, DA Sycheva, AL Khokhlova. 2-e izd. Moscow: GEOTAR-Media, 2024 (in Russian)]."},{"key":"ref7","unstructured":"\u0421\u044b\u0447\u0435\u0432 \u0414.\u0410. \u0422\u0435\u0440\u0430\u043f\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u044b\u0439 \u043c\u043e\u043d\u0438\u0442\u043e\u0440\u0438\u043d\u0433 \u2013 \u0438\u043d\u0441\u0442\u0440\u0443\u043c\u0435\u043d\u0442 \u043f\u0435\u0440\u0441\u043e\u043d\u0430\u043b\u0438\u0437\u0430\u0446\u0438\u0438 \u0444\u0430\u0440\u043c\u0430\u043a\u043e\u0442\u0435\u0440\u0430\u043f\u0438\u0438 \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u043e\u0432. \u0424\u0430\u0440\u043c\u0430\u043a\u043e\u0433\u0435\u043d\u0435\u0442\u0438\u043a\u0430 \u0438 \u0444\u0430\u0440\u043c\u0430\u043a\u043e\u0433\u0435\u043d\u043e\u043c\u0438\u043a\u0430. 2024;(2):3-4 [Sychev DA. Therapeutic drug monitoring is a tool for personalizing patients' pharmacotherapy. Pharmacogenetics and Pharmacogenomics. 2024;(2):3-4 (in Russian)]."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.54921\/2413-0346-2024-12-4-54-65"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.22.0188"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02787-2021"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.29413\/ABS.2018-3.2.13"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-024-03749-8"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2024.100444"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2023.102367"},{"key":"ref15","unstructured":"\u0422\u0443\u0431\u0435\u0440\u043a\u0443\u043b\u0435\u0437 \u0443 \u0432\u0437\u0440\u043e\u0441\u043b\u044b\u0445. \u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0438\u0438. 2024. \u0420\u0435\u0436\u0438\u043c \u0434\u043e\u0441\u0442\u0443\u043f\u0430: https:\/\/rof-tb.ru\/upload\/iblock\/140\/r9ijz6oxq65de3ud5unrvzfaph7hg7wi.pdf. \u0421\u0441\u044b\u043b\u043a\u0430 \u0430\u043a\u0442\u0438\u0432\u043d\u0430 \u043d\u0430 13.05.2025 [Tuberkulez u vzroslykh. Klinicheskie rekomendatsii. 2024. Available at: https:\/\/rof-tb.ru\/upload\/iblock\/140\/r9ijz6oxq65de3ud5unrvzfaph7hg7wi.pdf. Accessed: 13.05.2025 (in Russian)]."},{"key":"ref16","unstructured":"Technical manual for drug susceptibility testing of medicines used in the treatment of tuberculosis. 2018. Available at: www.who.int\/publications\/i\/item\/9789241514842. Accessed: 13.05.2025."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01908-2019"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170663"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.13.0268"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.01.001"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2215512120"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/691589\/226033","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/691589\/226033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:55:54Z","timestamp":1785448554000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/691589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":21,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,31]]}},"URL":"https:\/\/doi.org\/10.26442\/00403660.2026.07.203678","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"value":"2309-5342","type":"electronic"},{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,31]]}}}